Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activityCarolina S. Ilkow, John C. Bell, Almohanad A. Alkayyal et al.|Nature Medicine|2015Cited by 169
VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus InfectionRozanne Arulanandam, John C. Bell, Cory Batenchuk et al.|Cancer Cell|2015Cited by 104
Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell VaccineChantal G. Lemay, Rebecca C. Auer, Julia L. Rintoul et al.|Molecular Therapy|2012Cited by 93
Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killingRozanne Arulanandam, Jean‐Simon Diallo, Cory Batenchuk et al.|Nature Communications|2015Cited by 69
Model-based rational design of an oncolytic virus with improved therapeutic potentialFabrice Le Bœuf, John C. Bell, Cory Batenchuk et al.|Nature Communications|2013Cited by 44